USFDA completes pre-approval inspection at Biocon Malyasia
Form 483 issued with 6 observations
Biocon announced that USFDA has completed a pre-approval inspection of its manufacturing facility in Malaysia and issued a Form 483 with 6 observations.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 21 2018 | 9:22 AM IST